Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body
Portfolio Pulse from
Aclarion, Inc. has received a Notice of Allowance for its 24th US patent, expanding its proprietary rights to use Magnetic Resonance Spectroscopy (MRS) for identifying pain and infection biomarkers, specifically propionic acid, throughout the body.
February 11, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aclarion, Inc. has been granted a new US patent, enhancing its technology to use MRS for identifying pain and infection biomarkers, potentially increasing its market competitiveness.
The new patent strengthens Aclarion's intellectual property portfolio, potentially enhancing its competitive edge in the healthcare technology market. This could lead to increased investor confidence and a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100